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summary
Parasitic helminths (worms) cause serious infectious diseases in humans and domestic animals. Control of these infections
relies mostly on chemotherapeutics (the anthelmintics), but resistance has developed against most of these broad-spectrum
drugs in many parasite species. These resistant parasites are being used to elucidate the molecular mechanisms of drug
resistance and drug action. This has led to the development of sensitive assays to detect resistant parasites, but this has
not delayed the emergence of additional drug resistant parasite populations. Therefore, as development of new drugs by
pharmaceutical companies is slow, we may have to be prepared for a time when broad-spectrum drugs are no longer
effective, especially against worms of sheep.
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introduction
Nematode parasites cause serious morbidity and
mortality in humans and farm animals. Therefore
much research has been carried out on ways to
control these parasites, as eradication seems im-
possible. Several methods of control of these para-
sites have been investigated but the most frequently
used one is chemotherapy, especially since broad
spectrum drugs were introduced to the market. The
drugs used have caused hardly any drug resistance in
humans and cattle, but in sheep the abundant use of
anthelmintics has caused the selection of drug
resistant populations (Jackson, 1993; Prichard,
1994; Waller, 1994). Development of in vivo and
in vitro methods to measure the progress of the
selection for anthelmintic resistance has apparently
not resulted in the delay of the appearance of
resistance (Prichard, 1994; Coles & Klei, 1995;
Roos, Kwa & Grant, 1995; Waller et al. 1996). The
main reason may be the lack of information made
available to the farmer, a situation that is likely to
remain the same in the near future (Dangolla et al.
1996). As the development of new drugs is slow we
may have to be prepared for a time without broad-
spectrum drugs against sleep nematode parasites.
All means that are used to reduce the workload of
sheep diminish the selection pressure for natural
genetic resistance to these parasites. It is well known
that sheep breeds that are never treated by drugs
have a much higher level of natural resistance to
parasites than the breeds that are selected for high
production and that are regularly treated (Barger,
1989; Baker, 1995). This means that, when drugs
fail, farmers are in a worse situation compared to
before widespread drug use. However, within these
latter breeds there is much difference between the
sheep with regard to the worm load and this is
genetically inherited (Watson, Hosking & Hurford,
1992; Barger, 1993; Stear & Murray, 1994). There-
fore the gene(s) involved in the genetic resistance are
not lost from these sheep populations. It thus has
been possible to start breeding for genetic resistance
in the high production sheep breeds without pro-
duction loss (Barger, 1993). If these methods are
implemented by farmers they will reduce the need
for drugs, delay drug resistance and produces less
drug residue in milk and less environmental pol-
lution.
The development of genetic polymorphic markers,
microsatellite or others, for sheep and the mapping
of those on the sheep genome will enable us to
identify the markers and genes that are important for
genetic resistance (Broad & Hill, 1994; Stear et al.
1996). This will then be an easy tool to use in the
selection of the rams needed for breeding to increase
genetic resistance in the flock.
Although the breeding of genetically resistant
sheep will not eliminate the parasites but is likely to
diminish the incidence in sheep to 10–20% of what
it is now, it is a feasible method with the potential
advantage that is relatively available to all farmers
(Barger, 1993). It will greatly reduce the workload of
sheep and contamination of the fields. Together with
other control measures (see below), it should be
possible to reduce or replace anthelmintic use.
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control of helminth infections
To prevent human infections, non-invasive and
sanity measures, like intermediate host control,
improvements in housing, sewage disposal and water
supply are extremely important (Gutteridge, 1989).
This is illustrated by the fact that in most ‘developed
countries’ the level of infection of helminths in man
is very low without widespread chemotherapy or
vaccination. In contrast, the level of infections is
high in ‘developing countries’, where the implemen-
tation of hygiene is still low due to financial and
social problems (Guyatt & Evans, 1992). In farm
animals, where infection rates can be high due to
intensive farming methods, non-invasive methods
have also proved to be useful. Reduction of infection
by manipulation of the grazing environment limits
host–parasite contact, but most farmers are not able
to implement these measures (Jackson, 1993). Breed-
ing for genetic resistance of the host to the parasite
has been shown to be possible with several host
species, like cattle and sheep, but has not yet been
used much by farmers (Kloosterman, Parmentier &
Ploeger, 1992; Watson et al. 1992). This is probably
due to the fact that in order to select bulls or rams for
breeding, in the absence of molecular markers to
characterize animals, it would be necessary to infect
the animals with worms to determine their degree of
resistance.
Invasive control methods are chemotherapy and
vaccination. Extensive research has shown that there
is still a long way to go before effective vaccines
against human and animal helminths can be de-
veloped. The major problems to be overcome are the
manipulation by the parasite of the host immune
system and our still primitive knowledge of the basic
mechanisms of host–parasite interactions (Smith,
1992; Jasmer & McGuire, 1996). Anthelmintic drugs
are the most widely used means to control helminth
infections. They have so far failed to eradicate any
parasite species in specific geographical regions
because of the adaptability of the parasites when
under intensive selection pressure (Jackson, 1993;
Pritchard, 1994; Waller, 1994). Anthelmintics are
available now for the treatment of the major helminth
infections of humans and domestic animals (Gut-
teridge, 1989). Due to costs and logistics, however,
these drugs are not readily available to many people
and farm animals in developing countries. In con-
trast, they are being used extensively and successfully
in veterinary medicine in developed countries.
Unfortunately, irreversible resistance develops in
helminths, usually within 5 years of introduction of
the drug. Drug resistance of parasitic helminths is
becoming a serious problem in veterinary medicine,
especially in sheep husbandry. Sheep farmers cannot
farm profitably without extensive control of hel-
minth parasites. As resistance has been found now
against all major groups of broad-spectrum drugs,
management of chemotherapy, to delay or prevent
resistance, is imperative in this branch of agriculture
(Jackson, 1993; Waller et al. 1996).
Biological control methods, through the use of
nematophagous fungi, seem to be feasible for some
nematode parasites. The disadvantage is that the
adult parasites are not killed and only the eggs are
destroyed by the fungi. Furthermore, the host has to
be fed the fungi daily. It may be a useful method,
when integrated with other control strategies
(G; ronvold et al. 1993).
Methods on how to control parasites and delay
drug resistance have been investigated by math-
ematical modelling. Although these models are based
on a scant knowledge of parasite biology and
host–parasite interactions, they generate protocols
for experiments in the field. They suggest that to
delay anthelmintic resistance, administering drugs
from different groups simultaneously (Smith, 1990;
Barnes, Bobson & Barger, 1995) would be better
than rotating drugs on an annual basis. Another
method would be treating only 80–90% of the lambs
with drugs (Barnes et al. 1995). Field experiments
are needed, however, to confirm these approaches.
anthelmintic drugs
Since broad-spectrum drugs (that is, drugs that are
active against several unrelated species of parasites)
are available, they are the drugs of choice and used
most widely. There are only three groups of broad-
spectrum drugs available, each with a different mode
of action (see Martin, Robertson & Bjorn, this
volume). These drugs have the common feature
that they kill the parasites and do not harm the
host, when the prescribed concentrations are used
(Barragry, 1984a, b).
The first broad-spectrum group of drugs were the
benzimidazole (BZ) derivatives, initially marketed in
the 1960s. Different pharmaceutical}agrochemical
companies made their own derivatives from the same
core structure. The drugs all show cross-resistance.
Extensive studies indicated that BZ were antimitotics
that disrupted the microtubules and mitotic spindles
of the parasites, but not those of the host. The reason
for this differential action is still not entirely clear
(Lacey, 1988; Martin et al., this volume).
The second group of broad-spectrum drugs
became available in the early 1970s and comprises
the group of imidothiazoles, including levamisole
and tetramisole. The pyrimidines pyrantel and
morantel are classified in this group because there is
cross-resistance with the imidothiazoles (Prichard,
1994). The drugs cause spastic paralysis of the
parasite, which may not be killed immediately but is
expelled because of the paralysis. The exact mech-
anism of action is not known, although some recent
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data indicate that in the free-living nematode
Caenorhabditis elegans levamisole binds to a nicotinic
acetylcholine receptor (Lewis & Berberich, 1992;
Martin et al., this volume).
The third group of broad-spectrum drugs, the
avermectins, became available in the 1980s (Camp-
bell, 1993). These drugs are extremely effective
against nematodes and insects (Shoop, 1993). The
site of action of one of them, ivermectin, has been
studied. Results from crayfish and the nematode
Ascaris suum suggested an interaction with receptors
at chloride channels (Holden-Dye & Walker, 1990).
Subsequently, genes encoding ivermectin-sensitive
glutamate-gated chloride channel subunits were
isolated from the nematode C. elegans (Arena et al.
1995). At least one of these genes is expressed in the
pharyngeal muscle cells and this is consistent with
the hypothesis that ivermectin inhibits the phar-
yngeal pumping of nematodes (Geary et al. 1993). In
addition, binding of ivermectin to membrane trans-
porters like P-glycoprotein has been reported (Schin-
kel et al. 1994). The genetics of ivermectin resistance
seems to be simple: it is probably inherited as a
single dominant allele. This was suggested for the
nematode Haemonchus contortus (LeJambre et al.
1995; LeJambre, personal communication); using 2
different susceptible and 2 different resistant popula-
tions, it appeared that it was a classical example of
inheritance of resistance as one dominant allele.
The use of narrow-spectrum drugs diminished in
veterinary medicine after the broad-spectrum drugs
became available. However, against human schisto-
somiasis the specific drug praziquantel is used with
much success (Day, Bennett & Pax, 1992). The
precise mechanism of action is unclear (Martin et al.
this volume), but it has been shown that the immune
system of the host is needed, in addition to the drug,
to kill the worms. Another antischistosomal drug,
hycanthone, is also effective against some other
species of worms that reside in or feed from the host
blood (Cioli, Pica-Mattoccia & Archer, 1993).
development of drug resistance
The selection pressure of drugs to eradicate worms
has inevitably selected for drug-resistant parasites.
These drug-resistant parasites, however, are a key to
the elucidation of the molecular mechanism of action
of the drugs. Resistance has been reported against
the three groups of broad-spectrum drugs and on
some farms the parasites are resistant against several
groups of drugs. Assays to monitor the onset of
selection by each of the three drug groups are
needed, because timely rotation or mixtures of drugs
may delay and even select against resistance (Jack-
son, 1993; Roush, 1993). At the moment, however,
the assays available only detect resistance when
about 25% of the population is already resistant
(Jackson, 1993). As resistance is often caused by one
gene that is recessive (Roush, 1993), this means that
the gene frequency of the resistant gene is already 0±5
and reversion at that time is very difficult. Therefore,
much more sensitive assays are needed to investigate
the dynamics of resistance development. However,
influencing farmers’ habits to reduce or change the
use of anthelmintics may be difficult (Dangolla et al.
1996).
In human parasites, no resistance has been
convincingly shown yet against the three groups of
broad-spectrum drugs. This is probably due to a far
less frequent and better controlled use than in
veterinary medicine. A report from the WHO has
suggested, however, that there is resistance against
praziquantel in schistosomes (TDR News, 1992).
Resistance of schistosomes to hycanthone is well
documented and is a very nice illustration of the fact
that resistant populations can reveal the mechanism
of action of drugs. A parasite enzyme is able to
convert hycanthone to an unstable ester form that
then alkylates DNA and kills the parasite. Resistant
worms lack this enzyme activity (Cioli et al. 1993).
However, research into drug resistance and the
mechanism of anthelmintic action is not always that
straightforward. To investigate ivermectin resistance
in parasitic nematodes, one approach that was used
involved the study of resistant strains of the free-
living nematode C. elegans, which is susceptible to
the drug (Schaeffer & Haines, 1989). So far muta-
tions in more than 35 independent genes that are
responsible for various levels of resistance have been
identified (C. Johnson, personal communication).
Comparison with the development of drug resistance
in insects predicts that only a few of these mutations
are involved in the resistance mechanisms found in
the field (Roush, 1993). However, the mechanism of
the ivermectin resistance is still unknown, as the
membranes of ivermectin-resistant and -suscep-
tible larvae of H. contortus harbour similar numbers
of ivermectin-binding sites with the same affinity
characteristics (Rohrer et al. 1994). Our own results
indicate that a P-glycoprotein gene, which we cloned
from H. contortus, is not involved in ivermectin
resistance (M. S. G. Kwa & M. H. Roos, unpub-
lished).
Research into the mode of resistance to levamisole
has not yet elucidated the mechanism(s). Charac-
terization of the alpha chains of the nicotinic
acetylcholine receptor of two nematode species,
T. colubriformis and H. contortus, did not reveal any
difference in amino acid sequence between sus-
ceptible and resistant worms (Wiley et al., 1996,
Martin et al. this volume, Hoekstra et al. 1997).
We have been investigating the mechanism of
benzimidazole resistance in the sheep nematode
parasite H. contortus. The results, which indicate the
mechanism of drug action, are described below.
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molecular mechanisms of benzimidazole
resistance in the sheep nematode
H. CONTORTUS
Early studies on the mechanism of BZ resistance
indicated the presence in resistant worms of micro-
tubules that could not be disrupted at concentrations
of BZ that destroyed them in susceptible worms
(reviewed by Lacey, 1988). In vitro binding assays,
using partly purified tubulin preparations from
resistant and susceptible parasites, with tritiated BZ
indicated a lower binding of the drug in resistant
populations. This argues against gene amplification
of tubulins as the mechanism of resistance, because
in that case a higher binding of the drug in resistant
worms would have been found. When host tubulin
was used in these assays, it had the same low binding
as that from resistant worms (Lacey, 1988).
Extensive studies on the mechanism of BZ re-
sistance has been carried out in fungi, as BZ are also
fungicides (Davidse, 1986). In vitro mutagenesis of
several different species and site-directed muta-
genesis indicated that one point mutation in the b-
tubulin gene, that led to an amino acid change, was
enough to cause resistance (Thomas, Neff & Bot-
stein, 1985; Jung, Wilder & Oakley, 1992; Li et al.
1996). These mutations were not clustered but
spread out over the whole length of the gene.
Interestingly some recent resistant isolates from the
field of the yeast Venturia inaequalis showed only a
selected number of those in vitro generated muta-
tions, notably changes at amino acids 198 and 200
(Koenraadt, Sommerville & Jones, 1992).
In vitro mutagenesis studies were also carried out
with C. elegans for this anthelmintic group. The
C. elegans genome contains at least three loci for b-
tubulin, at one of which a gene is located that
determines BZ susceptibility. If this gene is deleted
or truncated, the worm is BZ resistant. Comparison
of the amino acid sequences between the 3 genes
indicated 6 differences between the gene conferring
susceptibility (ben-1) and the 2 conferring resistance
(mec-7 and tub-1) (Driscoll et al. 1989). Comparison
with the mutations in V. inequalis indicated that 2
different mutations, one at amino acid 198 (mec-7)
and one at amino acid 200 (tub-1), could be involved
in the resistance of the 2 genes.
We started the molecular characterization of
b-tubulin in benzimidazole-resistant (BZ-R) and
benzimidazole-susceptible (BZ-S) populations by
cloning a b-tubulin gene from a genomic library
constructed from a resistant population. This gene
was used as a probe on Southern blots with the DNA
from several BZ-susceptible and BZ-resistant popu-
lations. An extensive polymorphism, 5–10 bands,
was seen in susceptible populations, while in re-
sistant populations usually only one band was visible.
This indicated selection for this specific fragment.
An in vitro selection experiment confirmed this
conclusion and indicated in addition that the selected
fragment was already present at a low concentration
in the susceptible population that was used for the
selection. The dynamics of the selection indicated
that resistance was recessive (Roos, 1990; Roos et al.
1990, Roos & Boersema, 1991). Further charac-
terization of the apparently selected fragment by
restriction mapping of the upstream and downstream
regions of the gene indicated one b-tubulin gene in
resistant populations. This gene was probably func-
tional because there was transcription (Kwa et al.
1993a). Therefore we supposed that there was one
locus on which a gene was located with many
susceptible alleles and one, or a few, resistant ones.
We called these gene products b-tubulin isotype 1.
Selection pressure with BZ resulted in the survival
of the resistant worms that carried a specific b-
tubulin isotype 1 allele (Kwa et al. 1993b ; Roos,
Kwa & Grant, 1995).
The in vitro selection experiment, in which we
reached maximal resistance after 4 selection steps,
indicated that after 3 selection steps there was only
one b-tubulin isotype 1 gene left in the population.
There was, however, a doubling of the resistance
factor after the fourth selection step. By this time,
Geary et al. (1992) had published several b-tubulin
cDNA sequences from a susceptible population.
Differences in sequences and in reactions in South-
ern blots indicated 2 separate loci, one of which was
coding for a b-tubulin similar to the product of our
isotype 1 gene. The other sequences were called
isotype 2. Hybridization of a Southern blot using an
isotype 2 gene as probe indicated that in the fourth
selection step there was an elimination of worms
carrying this gene (Kwa et al. 1993a). Therefore 2
mechanisms of resistance were identified; at lower
resistance level there was a selection for a specific
isotype 1 gene, and at higher resistance levels there
was a deletion of worms with isotype 2 genes.
Further analysis of isotype 1 genes by amino acid
sequence comparison of ‘our’ resistant gene with
isotype 1 sequence 8–9 from Geary et al. (1992)
indicated 3 differences between the amino acid
sequences, at amino acids 76, 200 and 368. We
sequenced a susceptible gene also and there was only
one base difference that caused the amino acid
difference at 200 (Kwa, Veenstra & Roos, 1994). The
difference at amino acid 200, a Phe}Tyr transition,
was exactly the same difference as was found in the
resistant field isolates of V. inaequalis. Therefore we
constructed specific sense oligonucleotides, using
this mutation, that ended with a different 3«
nucleotide. These nucleotides were used in a PCR
and we were able to discriminate between BZ-R and
BZ-S populations isolated from Europe (Kwa et al.
1994). This indicated that in H. contortus a mutation
identical to the one in fungi could be responsible for
BZ resistance.
To investigate further the function of the poly-
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Fig. 1. A model for the mode of action of antimitotic drugs such as benzimidazoles (BZ) and colchicine. The box
shows the a- and b-subunits. Both the carboxy- (C) and amino-(N) terminal regions are indicated. In panel A, the
tubulin–BZ complex is about to be added to the growing microtubule. The b-tubulin carboxy terminus shows the
unfolding region induced by the drug binding. Since the rest of the b-tubulin is unaltered, interaction with a-tubulin
and addition to the growing microtubule is still possible. However, panel B shows that once added to the microtubule
the abnormally unfolded loop of b-tubulin prevents further addition of sub-units, thereby inhibiting further
microtubule polymerization (Kwa, 1994, modified after Mitchison, 1993; Sackett & Verma, 1993; Uppuluri et al. 1993).
morphism at amino acid 200, we used the free-living
nematode C. elegans as an expression system. A BZ-
R strain, ben-1, of C. elegans was transformed with a
b-tubulin isotype 1 gene isolated from a BZ-S
H. contortus population. Expression of the H. con-
tortus gene altered the phenotype of transgenic
C. elegans from resistant to susceptible. Introduction
of the Phe to Tyr substitution of this parasite gene at
amino acid 200 by in vitro mutagenesis resulted in
the loss of reverting activity (Kwa et al. 1995). This
indicates that this substitution can play a direct role
in determining BZ susceptibility and excludes the
possibility that the Phe to Tyr substitution is simply
tightly linked to some other, unknown, resistance
determinant. Similarly, transformation of BZ-R
C. elegans with a cloned susceptibility allele of
T. colubriformis resulted in partial reversion in partial
reversion of the resistance, whereas transformation
with a resistance allele did not (W. N. Grant,
personal communication).
Our recent studies, using the allele-specific PCR
to detect susceptible and resistant b-tubulin alleles,
indicate that susceptible isotype 1 alleles can be
found only on farms that do not use benzimidazoles
(M. H. Roos et al., unpublished). This fits in with
our previous results on in vitro selection for BZ
resistance (Roos et al. 1995). The loss of the sus-
ceptible alleles in this very early stage of the selection
shows that reversion of resistance may be a remote
possibility in delaying or stopping BZ resistance.
role of mutations in b-tubulin in bz
resistance
How the point mutations in b-tubulin affect BZ
resistance is difficult to investigate. b-tubulin is a
GTP-binding protein and GTP is needed for
assembly, with b-tubulin, of the microtubules.
However, it has never been crystallized and the
secondary and tertiary structures of the molecule are
not known (Sternlicht, Yaffe & Farr, 1987). The fact
that BZ drugs are nucleotide analogues, and codon
200 is located near the nucleotide binding domain II,
suggests that a slight conformational change may
alter the properties of the GTP binding. Indeed,
site-directed mutagenesis studies of mammalian
brain b-tubulin (Farr & Sternlicht, 1992) involving,
for instance, amino acid residue 197 enhanced
affinity for all nucleotides. Several studies suggest
that resistance to antimitotic drugs correlates with an
increase of the level of polymerized tubulin (Minotti,
Barlow & Cabral, 1991), or with enhancement of
microtubule stability (Schibler & Huang, 1991). A
structural model by Mitchison (1993) predicted the
localization of the exchangeable GTP-binding site at
the plus end of microtubules, indicating its im-
portance for polymerization. This is supported by
recent biochemical evidence, which demonstrates
that the classic antimitotic drug colchicine, binds to
2 regions in mammalian brain b-tubulin (amino
acids 1–46 and 214–242) (Uppuluri et al. 1993) and
thereby induces local unfolding of a small region in
the carboxy-terminus around amino acid 390. This
is shown diagrammatically in Fig. 1.
conclusions
The future control of helminth parasites will depend
on proper use of all possible means to eradicate
them. Whichever method is used, however, if it
prevents or reduces contact between parasite and
host it will diminish the selection for natural
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resistance to parasites in the sheep. Unfortunately,
mathematical models have not included the breeding
for genetic resistance in sheep, otherwise we would
know more about integrating this method with other
means for control. As reversion or delay of drug
resistance is not a real possibility, we have to take
care that natural resistance is brought back to the
original level in the sheep breeds. This will be an
important contribution to controlling the worm load
and can be implemented by all farmers if easy
methods for typing are developed. Therefore re-
search is needed to find the molecular markers that
are linked with this resistance in all the major breeds
of sheep. These markers could also be used to locate
and investigate, by linkage analysis, the functional
genes involved in the resistance of sheep. In the
future, these genes could be used to inject sheep
embryos to make transgenic resistant sheep. The
advantage is that there will be no need for selecting
and breeding for resistance of the different breeds.
Moreover, the chances for selection of worms that
can escape the genetic resistance in sheep seems
remote (Woolaston, Elwin & Barger, 1992). We have
to restore the innate parasite resistance to sheep,
otherwise, after breakdown of the broad-spectrum
drugs, the farmers will be in a far worse situation
than before these drugs became available.
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